𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Measurement of bioreactor perfusion using dynamic contrast agent-enhanced magnetic resonance imaging

✍ Scribed by Peter E. Thelwall; André A. Neves; Kevin M. Brindle

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
508 KB
Volume
75
Category
Article
ISSN
0006-3592

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reconstruction of 3D dynamic contrast-en
Reconstruction of 3D dynamic contrast-enhanced magnetic resonance imaging using nonlocal means
✍ Ganesh Adluru; Tolga Tasdizen; Matthias C. Schabel; Edward V.R. DiBella 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

Purpose: To develop and test a nonlocal means-based reconstruction algorithm for undersampled 3D dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) of tumors. ## Materials and Methods: We propose a reconstruction technique that is based on the recently proposed nonlocal means (NLM)

Importance of perfusion in myocardial vi
Importance of perfusion in myocardial viability studies using delayed contrast-enhanced magnetic resonance imaging
✍ Erik Hedström; Håkan Arheden; Rolf Eriksson; Lars Johansson; Håkan Ahlstrom; Tom 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

## Abstract ## Purpose To investigate whether an extracellular gadolinium‐(Gd)‐based contrast agent (CA) enters nonperfused myocardium during acute coronary occlusion, and whether nonperfused myocardium presents as hyperintense in delayed contrast‐enhanced (DE) MR images in the absence of CA in th

Vascular perfusion of human lung cancer
Vascular perfusion of human lung cancer in a rat orthotopic model using dynamic contrast-enhanced magnetic resonance imaging
✍ Yael Rosen; Gregory Ramniceanu; Raanan Margalit; Dov Grobgeld; Raya Eilam; Hadas 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB 👁 1 views

## Abstract Lung cancer is the leading cause of death among cancers. Early detection and diagnosis present a major goal in the efforts to improve survival rates of lung cancer patients. Changes in angiogenic activity and microvascular perfusion properties in cancers can serve as markers of malignan